Smith Nicholas Conrad bought ANRO
September 29, 2026 · Form 4 insider transaction
Smith Nicholas Conrad bought 56,455 shares of Alto Neuroscience, Inc. at $2.35 per share, a transaction worth $132.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
56,455
Price
$2.35
Total value
$132.7K
InsiderSmith Nicholas Conrad
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 29, 2026
Filing dateOctober 1, 2026
Shares owned after80,515
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.